ea0057004 | GLP-1 analogs protect beta cells and prevent diabetes in models of Wolfram syndrome | BES2018
Mariana Igoillo-Esteve
, Sanna Toivonen
, Paraskevi Salpea
, Cristina Cosentino
, Bahareh Rajaei
, Anyishai Musuaya
, Nathalie Pachera
, Piero Marchetti
, Cris Brown
, Fumihiko Urano
, Eizirik Decio L
, Miriam Cnop
Background and aims: Wolfram syndrome is a rare autosomal recessive orphan disease. The clinical manifestations are young onset diabetes, optic nerve atrophy and deafness. Most Wolfram patients carry mutations in WFS1. WFS1 deficiency results in endoplasmic reticulum (ER) stress, leading to neurodegeneration and pancreatic β-cell dysfunction and death. Glucagon-like peptide-1 (GLP-1) analogs and the cAMP inducer forskolin have been shown to protect β-cells f...